These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26702078)

  • 1. Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up.
    Buglioni A; Cannone V; Sangaralingham SJ; Heublein DM; Scott CG; Bailey KR; Rodeheffer RJ; Sarzani R; Burnett JC
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.
    Cannone V; Buglioni A; Sangaralingham SJ; Scott C; Bailey KR; Rodeheffer R; Redfield MM; Sarzani R; Burnett JC
    Mayo Clin Proc; 2018 Aug; 93(8):980-990. PubMed ID: 30077215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.
    Buglioni A; Cannone V; Cataliotti A; Sangaralingham SJ; Heublein DM; Scott CG; Bailey KR; Rodeheffer RJ; Dessì-Fulgheri P; Sarzani R; Burnett JC
    Hypertension; 2015 Jan; 65(1):45-53. PubMed ID: 25368032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Natural History of Patients With Isolated Metabolic Syndrome.
    Patel PA; Scott CG; Rodeheffer RJ; Chen HH
    Mayo Clin Proc; 2016 May; 91(5):623-33. PubMed ID: 27063063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.
    Echouffo-Tcheugui JB; Zhao S; Brock G; Matsouaka RA; Kline D; Joseph JJ
    Diabetes Care; 2019 Mar; 42(3):486-493. PubMed ID: 30659073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.
    Yiu KH; Lau KK; Zhao CT; Chan YH; Chen Y; Zhen Z; Wong A; Lau CP; Tse HF
    Cardiovasc Diabetol; 2014 Mar; 13():63. PubMed ID: 24661773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; Marx N;
    Circulation; 2019 Jan; 139(3):351-361. PubMed ID: 30586723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.
    Papademetriou V; Lovato L; Tsioufis C; Cushman W; Applegate WB; Mottle A; Punthakee Z; Nylen E; Doumas M;
    Am J Nephrol; 2017; 45(2):136-145. PubMed ID: 27992863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
    Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
    Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between diabetes mellitus and hypertension with anthropometric indicators in older adults: results of the Mexican Health Survey, 2000.
    Sánchez-Viveros S; Barquera S; Medina-Solis CE; Velázquez-Alva MC; Valdez R
    J Nutr Health Aging; 2008 May; 12(5):327-33. PubMed ID: 18443716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low plasma 1,25(OH)
    Masson S; Barlera S; Colotta F; Magnoli M; Bonelli F; Moro M; Marchioli R; Tavazzi L; Tognoni G; Latini R
    Int J Cardiol; 2016 Dec; 224():220-225. PubMed ID: 27657477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Chan YH; Hai JSH; Lau KK; Tse HF
    Cardiovasc Diabetol; 2021 Apr; 20(1):88. PubMed ID: 33894788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and glomerular filtration--observations in the general population.
    Hannemann A; Rettig R; Dittmann K; Völzke H; Endlich K; Nauck M; Wallaschofski H
    BMC Nephrol; 2014 Mar; 15():44. PubMed ID: 24612948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.
    Queisser N; Schupp N
    Free Radic Biol Med; 2012 Jul; 53(2):314-27. PubMed ID: 22609249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.
    de Haro Moraes C; Figueiredo VN; de Faria AP; Barbaro NR; Sabbatini AR; Quinaglia T; Ferreira-Melo SE; Martins LC; Demacq C; Júnior HM
    J Hum Hypertens; 2013 Apr; 27(4):225-30. PubMed ID: 22810172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism.
    Güder G; Hammer F; Deutschbein T; Brenner S; Berliner D; Deubner N; Bidlingmaier M; Ertl G; Allolio B; Angermann CE; Fassnacht M; Störk S
    J Card Fail; 2015 Mar; 21(3):208-16. PubMed ID: 25573831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based care for the specialized management of heart failure: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Deo R; Yang W; Khan AM; Bansal N; Zhang X; Leonard MB; Keane MG; Soliman EZ; Steigerwalt S; Townsend RR; Shlipak MG; Feldman HI;
    Hypertension; 2014 Jul; 64(1):103-10. PubMed ID: 24752431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.
    Rao AD; Shah RV; Garg R; Abbasi SA; Neilan TG; Perlstein TS; Di Carli MF; Jerosch-Herold M; Kwong RY; Adler GK
    Am J Cardiol; 2013 Jul; 112(1):73-8. PubMed ID: 23597770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.